PAD 112 (Moexipril 15 mg)
Pill imprint PAD 112 has been identified as Moexipril hydrochloride 15 mg.
Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PAD 112
- 15 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Paddock Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
|NDC Code||Manufacturer / Repackager|
|54569-5916||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
More about moexipril
- Other brands: Univasc
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.